Fate Therapeutics Reports First Quarter 2016 Financial Results

Go back to Fate Therapeutics Reports First Quarter 2016 Financial Results
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.16 +0.01 (0.47%)
Previous Close $2.15    52 Week High $4.76 
Open $2.10    52 Week Low $1.46 
Day High $2.32    P/E N/A 
Day Low $2.07    EPS $-1.91 
Volume 7,846,050